Effects of plasma estrogen sulfates in mammary... [Endocrinology. 1980] - PubMed

loading

Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors. [J Steroid Biochem. 1980]
Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors.
Rochefort H, André J, Baskevitch PP, Kallos J, Vignon F, Westley B. J Steroid Biochem. 1980 Jan; 12:135-42.
Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. [Breast Cancer Res Treat. 1986]
Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells.
Pasqualini JR, Gelly C, Lecerf F. Breast Cancer Res Treat. 1986; 8(3):233-40.
Heterogeneity of estrogen binding sites in mammary tumors. [Breast Cancer Res Treat. 1983]
Heterogeneity of estrogen binding sites in mammary tumors.
Clark JH, Watson CS, Markaverich BM, Syne JS, Panko WB. Breast Cancer Res Treat. 1983; 3(1):61-5.
Review Estrogen receptors in the spectrum of breast cancer. [Curr Probl Cancer. 1976]
Review Estrogen receptors in the spectrum of breast cancer.
Leclercq G, Heuson JC. Curr Probl Cancer. 1976 Dec; 1(6):1-34.
Review [Treatment of malignant breast tumors containing estrogen receptors]. [Vopr Onkol. 1982]
Review [Treatment of malignant breast tumors containing estrogen receptors].
El'tsina NV. Vopr Onkol. 1982; 28(4):95-102.

A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells. [Environ Health Perspect. 2002]
A novel endocrine-disrupting agent in corn with mitogenic activity in human breast and prostatic cancer cells.
Markaverich B, Mani S, Alejandro MA, Mitchell A, Markaverich D, Brown T, Velez-Trippe C, Murchison C, O'Malley B, Faith R. Environ Health Perspect. 2002 Feb; 110(2):169-77.
ICI 164,384: a control for investigating estrogen responsive genes. [Nucleic Acids Res. 1993]
ICI 164,384: a control for investigating estrogen responsive genes.
Bondy KL, Zacharewski TR. Nucleic Acids Res. 1993 Nov 11; 21(22):5277-8.
Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. [Proc Natl Acad Sci U S A. 1984]
Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7.
Brown AM, Jeltsch JM, Roberts M, Chambon P. Proc Natl Acad Sci U S A. 1984 Oct; 81(20):6344-8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Effects of plasma estrogen sulfates in mammary cancer cells.
Effects of plasma estrogen sulfates in mammary cancer cells.
Endocrinology. 1980 Apr ;106(4):1079-86.

PubMed
Neuropsychologic impairment in astrocytoma survivors.
Neuropsychologic impairment in astrocytoma survivors.
Neurology. 1980 Feb ;30(2):172-7.

PubMed
Activity and activation of the granulocyte superoxide-generating system.
Activity and activation of the granulocyte superoxide-generating system.
Blood. 1980 Jan ;55(1):85-92.

PubMed
Benign intracranial hypertension after minocycline therapy.
Benign intracranial hypertension after minocycline therapy.
Eur Neurol. 1978 ;17(1):48-9.

PubMed
The lambda and P22 phage repressors.
The lambda and P22 phage repressors.
J Biomol Struct Dyn. 1983 Dec ;1(4):1011-22.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed